Literature DB >> 24361400

Potential of resveratrol in the treatment of heart failure.

Pema Raj1, Xavier Lieben Louis1, Sijo Joseph Thandapilly1, Ali Movahed2, Shelley Zieroth3, Thomas Netticadan4.   

Abstract

The concept of food has expanded beyond its traditional role of survival and hunger satisfaction, to include a role in the prevention and treatment of disease. Polyphenols are classes of compounds that are synthesized by plants to serve a wide variety of functions including growth pollination and defense. These compounds have recently received increased attention in medical research. In this group, one of the most studied has been resveratrol (3,5,4,-trihydroxystilbene), a polyphenol, which is found predominantly in grapes and berries. Over the past two decades, researchers have studied the ability of resveratrol to prevent or reverse the development of abnormalities in heart structure and function in animal models of heart disease and heart failure. The results from animal studies have been promising, and very recently, this knowledge has been translated into examining the efficacy of resveratrol in humans with heart disease/failure. In this review we will discuss the current status of resveratrol research on cardioprotection.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardioprotection; Heart disease; Heart failure; Polyphenols; Resveratrol

Mesh:

Substances:

Year:  2013        PMID: 24361400     DOI: 10.1016/j.lfs.2013.12.011

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  27 in total

Review 1.  Nuclear Factor (Erythroid-Derived 2)-Like 2 and Thioredoxin-1 in Atherosclerosis and Ischemia/Reperfusion Injury in the Heart.

Authors:  Philipp Jakobs; Vlad Serbulea; Norbert Leitinger; Anna Eckers; Judith Haendeler
Journal:  Antioxid Redox Signal       Date:  2017-01-18       Impact factor: 8.401

2.  Resveratrol and exercise.

Authors:  Saltuk Bugra Baltaci; Rasim Mogulkoc; Abdulkerim Kasim Baltaci
Journal:  Biomed Rep       Date:  2016-10-11

Review 3.  Resveratrol and cardiovascular system-the unfulfilled hopes.

Authors:  Małgorzata Chudzińska; Daniel Rogowicz; Łukasz Wołowiec; Joanna Banach; Sławomir Sielski; Robert Bujak; Anna Sinkiewicz; Grzegorz Grześk
Journal:  Ir J Med Sci       Date:  2020-11-21       Impact factor: 1.568

4.  Beneficial effects of combined resveratrol and metformin therapy in treating diet-induced insulin resistance.

Authors:  Scott Frendo-Cumbo; Rebecca E K MacPherson; David C Wright
Journal:  Physiol Rep       Date:  2016-08

5.  Convergent Effects of Resveratrol and PYK2 on Prostate Cells.

Authors:  Andrea Conte; Annamaria Kisslinger; Claudio Procaccini; Simona Paladino; Olimpia Oliviero; Francesca de Amicis; Deriggio Faicchia; Dominga Fasano; Marilena Caputo; Giuseppe Matarese; Giovanna Maria Pierantoni; Donatella Tramontano
Journal:  Int J Mol Sci       Date:  2016-09-13       Impact factor: 5.923

6.  Resveratrol Reverses Functional Chagas Heart Disease in Mice.

Authors:  Glaucia Vilar-Pereira; Vitor C Carneiro; Hilton Mata-Santos; Amanda R R Vicentino; Isalira P Ramos; Naira L L Giarola; Daniel F Feijó; José R Meyer-Fernandes; Heitor A Paula-Neto; Emiliano Medei; Marcelo T Bozza; Joseli Lannes-Vieira; Claudia N Paiva
Journal:  PLoS Pathog       Date:  2016-10-27       Impact factor: 6.823

7.  Postnatal resveratrol supplementation improves cardiovascular function in male and female intrauterine growth restricted offspring.

Authors:  Amin Shah; Anita Quon; Jude S Morton; Sandra T Davidge
Journal:  Physiol Rep       Date:  2017-01

8.  Resveratrol improves cardiac function and left ventricular fibrosis after myocardial infarction in rats by inhibiting NLRP3 inflammasome activity and the TGF-β1/SMAD2 signaling pathway.

Authors:  Jinjin Jiang; Xiuping Gu; Huifeng Wang; Shibin Ding
Journal:  PeerJ       Date:  2021-05-28       Impact factor: 2.984

Review 9.  Resveratrol and Cardiovascular Diseases.

Authors:  Dominique Bonnefont-Rousselot
Journal:  Nutrients       Date:  2016-05-02       Impact factor: 5.717

10.  The efficacy of resveratrol in controlling hypertension: study protocol for a randomized, crossover, double-blinded, placebo-controlled trial.

Authors:  Ali Movahed; Afshin Ostovar; Daryoush Iranpour; Sijo Joseph Thandapilly; Pema Raj; Xavier Lieben Louis; James Michael Smoliga; Thomas Netticadan
Journal:  Trials       Date:  2016-06-23       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.